Albert Bourla, Pfizer CEO (Lintao Zhang/Getty Images)
Pfizer lays out ambitious vision for cancer portfolio in bid to reinvigorate its business
Pfizer hopes that its current pipeline could deliver at least eight cancer blockbuster drugs by 2030 as part of its strategy to double down on …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
